Tetrindole

Tetrindole
Systematic (IUPAC) name
	2,3,3a,4,5,6-Hexahydro-8-cyclohexyl-1H-pyrazino[3,2,1-j,k]carbazole
Identifiers
ATC code	None
PubChem	CID 160020
ChemSpider	140675
ChEBI	CHEBI:77799
Chemical data
Formula	C20H26N2
Molar mass	294.43 g/mol
	SMILES C1CCC(CC1)C2=CC3=C(C=C2)N4CCNC5C4=C3CCC5 ;
	InChI InChI=1S/C20H26N2/c1-2-5-14(6-3-1)15-9-10-19-17(13-15)16-7-4-8-18-20(16)22(19)12-11-21-18/h9-10,13-14,18,21H,1-8,11-12H2 ; Key:AUXCHYJDVJZEPG-UHFFFAOYSA-N ;
(what is this?) (verify)

Tetrindole was a drug candidate that functions by reversibly inhibiting monoamine oxidase A; it was first synthesized in Moscow in the early 1990s.^[1] Tetrindole is similar in its chemical structure to pirlindole (Pyrazidol), and metralindole.^[2]

References[edit]

^ Medvedev, AE; Kirkel, AA; Kamyshanskaya, NS; Moskvitina, TA; Axenova, LN; Gorkin, VZ; Andreeva, NI; Golovina, SM; Mashkovsky, MD (20 January 1994). "Monoamine Oxidase Inhibition by Novel Antidepressant Tetrindole". Biochemical Pharmacology 47 (2): 303–8. doi:10.1016/0006-2952(94)90021-3. PMID 8304974. |access-date= requires |url= (help)
^ Ramsay, RR; Gravestock, MB (March 2003). "Monoamine Oxidases: to Inhibit or Not to Inhibit". Mini Reviews in Medicinal Chemistry 3 (2): 129–36. PMID 12570845. |access-date= requires |url= (help)

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.